Why the study?
Does CDC5L overexpression improve myocardial regeneration and reduce ischemia-reperfusion injury in mouse models?
Population
In vitro oxygen-glucose deprivation/reoxygenation model in neonatal mouse cardiomyocytes and in vivo…
Comparison
Modulation of CDC5L expression via adenoviral or… vs Control
Design
Preclinical
Key result
CDC5L overexpression attenuated cardiac ischemia-reperfusion injury by promoting cardiomyocyte proliferation and inhibiting apoptosis through the FGF10-YAP pathway.
Authors
Loading...
Hypothesis-generating for CDC5L as a myocardial regeneration target; leaves open translation to human ischemia-reperfusion injury.
Does CDC5L overexpression improve myocardial regeneration and reduce ischemia-reperfusion injury in mouse models?
CDC5L attenuates cardiac ischemia-reperfusion injury by promoting cardiomyocyte proliferation and inhibiting apoptosis through the FGF10-YAP pathway, representing a potential therapeutic target for myocardial regeneration.
Wei et al. (2025) studied Myocardial ischemia-reperfusion injury. CDC5L overexpression or knockdown was evaluated on Cardiomyocyte proliferation, apoptosis, and cardiac function. CDC5L overexpression attenuated cardiac ischemia-reperfusion injury by promoting cardiomyocyte proliferation and inhibiting apoptosis through the FGF10-YAP pathway.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: